布罗利祖马布诱导的二次性皮质下降症表现为暂时性缺血性发作
1Neurology & Neurophysiology Center Vienna Austria.
Clinical case reports
|January 31, 2025
概括
布罗利祖马布是一种癌症免疫疗法,很少会导致皮质下降症,导致头和失言症等症状. 这种以低皮质醇为特征的情况,需要立即用皮质治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 布罗利祖马布是一种免疫检查点抑制剂,向PD-1受体.
- 虽然它在癌症治疗中有效,但可能会导致罕见的副作用.
- 低皮质性是与布罗利祖马布治疗相关的记录,尽管不常见的不良事件.
研究的目的:
- 为了呈现布罗利祖马布诱导的皮质过低症的一个案例.
- 要突出这种罕见的副作用的神经表现.
- 强调在接受 pembrolizumab 治疗的患者中识别皮质下降症的重要性.
主要方法:
- 一个67岁的男性患有尿路癌的病例报告.
- 详细描述了患者在佩布罗利祖马布治疗后的症状.
- 血清皮质醇水平的实验室评估和缺皮质症的临床诊断.
主要成果:
- 患者出现了包括恶心,吐,皮疹,失言症和头等症状.
- 血清皮质醇水平显著降低证实了皮质过低.
- 在用皮治疗后症状消失.
结论:
- 布罗利祖马布可以诱导皮质下降症,即使是在之前无故意给予之后.
- 皮质下降症可能伴有神经症状,如动脉低血压,大脑低 perfusion,.
- 医生必须警二次皮质下降症,因为这是布罗利祖马布的累积毒性.
相关概念视频
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...


